Figure 3From: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatmentCumulative incidence of metachronous ipsilateral breast cancer in women with (--) and in those without (--) germline BRCA mutations (P = 0.68).Back to article page